Pharmaniaga seen as among frontrunners for vaccine tender


MIDF Research said Pharmaniaga has several advantages to clinch the fill and finish tender given its well-established logistics and distribution network nationwide.

PETALING JAYA: Positive developments in the development of a Covid-19 vaccine will continue to lift interest in local pharmaceutical manufacturers, including Pharmaniaga Bhd, which is touted to be among the frontrunners to win a tender for the vaccine.

MIDF Research said Pharmaniaga has several advantages to clinch the fill and finish tender given its well-established logistics and distribution network nationwide.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Oharmaniaga , vaccine , frontrunners , Doupharma ,

Next In Business News

Oil drops as Trump calms Iran fears; tech stocks slide in Asia
Bank Negara's OPR expected to remain at 2.75% throughout 2026 - BMI
Ringgit edges up as softer US yields weigh on greenback�
Global trade finance gap at US$2.5 trillion as global trade tensions rise, ADB says
FBM KLCI hovers above 1,700 support
Former army chief Zamrose resigns as Boustead Heavy Industries director
Trading ideas: Sunview, TNB, Capital A, Keyfield, TRC, Rexit, Pestec, AirAsia X, Hibiscus, Selangor Dredging, BHIC, Globetronics
Oil reverses gains after Trump eases worries over Iran
Wall Street ends lower, led by drop in Nasdaq
Czech ammunition-maker CSG plans Amsterdam IPO

Others Also Read